SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-065476
Filing Date
2018-12-20
Accepted
2018-12-19 19:50:11
Documents
1
Period of Report
2019-01-23
Effectiveness Date
2018-12-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY SATEMENT tv508590-def14a.htm DEF 14A 481268
  Complete submission text file 0001144204-18-065476.txt   482356
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13341 | Film No.: 181244461
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1